ที่ FPI Ref. FPI.011/2019 14 November 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2019 To : Board of Directors and President of The Stock Exchange of Thailand
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
Discussion and Analysis of Financial Condition and Results of Operations for the year 2556 Translation UWC 031/2560 August 10, 2017 Subject : Management Discussion and Analysis for quarter 2-2017 To
หน้าที 1 จาก 5 GEL.CS.019/2560 15 August 2017 Subject Explanation and analysis of management for operating results of the Second Quarter Ended June 30, 2017 To Director and Manager The Stock Exchange
the increased in number of staff and management to support Testing and Inspection service business, especially in eastern region. The staff cost has been increased 92.75% compared to the same period of
Microsoft Word - Ref FPI.028.2017.doc Ref. FPI.028/2017 9 November 2017 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2017 To : Board of Directors and President of
หน้าที่ 1 จาก 5 GEL.CS.024/2560 15 November 2017 Subject Explanation and analysis of management for operating results of the Third Quarter Ended September 30, 2017 To Director and Manager The Stock
well as a result from the better cash flow management. 2. The increase of the capital in a joint venture in the amount of THB 164 million 3. The decrease of the land, buildings, and equipment in the